revealed that high levels of CD8+CD28+ T cells in peripheral blood before anti-tumor treatment (chemotherapy/radiation/immunotherapy/surgery) were associated with prolonged progression-free survival and overall survival (58, 60). Here, CD8A is linked to neoplasm.